Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Iboro Nta"'
Predictors of loss to follow-up in art experienced patients in Nigeria: a 13 year review (2004–2017)
Autor:
Ahmad Aliyu, Babatunde Adelekan, Nifarta Andrew, Eunice Ekong, Stephen Dapiap, Fati Murtala-Ibrahim, Iboro Nta, Nicaise Ndembi, Charles Mensah, Patrick Dakum
Publikováno v:
AIDS Research and Therapy, Vol 16, Iss 1, Pp 1-9 (2019)
Abstract Background Expanded access to antiretroviral therapy (ART) leads to improved HIV/AIDS treatment outcomes in Nigeria, however, increasing rates of loss to follow-up among those on ART is threatening optimal standard achievement. Therefore, th
Externí odkaz:
https://doaj.org/article/17cfacdc43dd4b15aaa648d8a277eeab
Autor:
Babatunde Adelekan, Nifarta Andrew, Iboro Nta, Asabe Gomwalk, Nicaise Ndembi, Charles Mensah, Patrick Dakum, Ahmad Aliyu
Publikováno v:
AIDS Research and Therapy, Vol 16, Iss 1, Pp 1-7 (2019)
Abstract Background People living with HIV (PLHIV) constantly need to address social issues such as the cost of accessing care, stigma, and lack of social support which impacts on their level of adherence to clinic visits or antiretroviral treatment
Externí odkaz:
https://doaj.org/article/d1e9b2db4de740cc864c58b7b87d5607
Autor:
Gbenga A. Kayode, Echezona E. Ezeanolue, Prosper Okonkwo, Michael Odutola, Hadiza Khamofu, Iboro Nta, John Oko Okpanachi, Yohanna Kambai Avong, Nicaise Ndembi, Charles Mensah, James Okuma, Patrick Dakum
Publikováno v:
BMC Public Health, Vol 20, Iss 1, Pp 1-7 (2020)
BMC Public Health
BMC Public Health
Background The Nigerian HIV Geriatric Cohort (NHGC) is a longitudinal cohort setup to learn how elderly people living with HIV (EPLHIV) in Nigeria fare, despite not being prioritized by the national treatment program, and to deepen knowledge for thei
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31ef7c232f06b5b7c96e5669f847ec5b
https://doi.org/10.21203/rs.2.18662/v5
https://doi.org/10.21203/rs.2.18662/v5
Predictors of loss to follow-up in art experienced patients in Nigeria: a 13 year review (2004–2017)
Autor:
Charles Mensah, Babatunde Adelekan, Nicaise Ndembi, Nifarta Andrew, Patrick Dakum, Eunice Ekong, Fati Murtala-Ibrahim, Iboro Nta, Stephen Dapiap, Ahmad Aliyu
Publikováno v:
AIDS Research and Therapy
AIDS Research and Therapy, Vol 16, Iss 1, Pp 1-9 (2019)
AIDS Research and Therapy, Vol 16, Iss 1, Pp 1-9 (2019)
BackgroundExpanded access to antiretroviral therapy (ART) leads to improved HIV/AIDS treatment outcomes in Nigeria, however, increasing rates of loss to follow-up among those on ART is threatening optimal standard achievement. Therefore, this retrosp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::adbfb54162d5dabe7783bbee0158d58f
https://doi.org/10.1186/s12981-019-0241-3
https://doi.org/10.1186/s12981-019-0241-3
Autor:
Ahmad Aliyu, Babatunde Adelekan, Nicaise Ndembi, Iboro Nta, Asabe Gomwalk, Nifarta Andrew, Patrick Dakum, Charles Mensah
Publikováno v:
AIDS Research and Therapy
AIDS Research and Therapy, Vol 16, Iss 1, Pp 1-7 (2019)
AIDS Research and Therapy, Vol 16, Iss 1, Pp 1-7 (2019)
Background People living with HIV (PLHIV) constantly need to address social issues such as the cost of accessing care, stigma, and lack of social support which impacts on their level of adherence to clinic visits or antiretroviral treatment leading t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::577c07bb1eb5ceec0b00594ec680003d
https://doi.org/10.1186/s12981-019-0231-5
https://doi.org/10.1186/s12981-019-0231-5
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Babatunde Adelekan, Ahmad Aliyu, Iboro Nta, Stephen Dapiap, Eunice Ekong, Fati Murtala-Ibrahim, Patrick Dakum, Nifarta Andrew, Nicaise Ndembi, Charles Mensah
Publikováno v:
BMJ Global Health. 4:A20.3-A21
BackgroundExpanded access to antiretroviral therapy (ART) has improved HIV outcomes in Nigeria. However, increasing rates of patients lost to follow-up (LTFU) is threatening the achievement of the UNAIDS treatment targets to treat 90% of HIV-diagnose
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dc0760c5cd5166afc6dab3f3f9fc1ef7
https://doi.org/10.1136/bmjgh-2019-edc.51
https://doi.org/10.1136/bmjgh-2019-edc.51
Autor:
Olabanjo Ogunsola, Fei Badejo, Iboro Nta, Olawale Fadare, Echezona E. Ezeanolue, Jude Ilozumba, Olusegun Adesola Busari, Nadia A. Sam-Agudu
Publikováno v:
JAIDS Journal of Acquired Immune Deficiency Syndromes. 81:75-75
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b827de4825f751f1ed27e254a4a9376d
https://doi.org/10.1097/01.qai.0000558032.54902.6e
https://doi.org/10.1097/01.qai.0000558032.54902.6e
Autor:
Young Oluokun, Hyacinth I Nnaemeka, Sunny Phillips, Oriaku Ofem, Patrick Dakum, Imoiboho Williams, Uteng Wilson, Tongdiyen L Jasper, Iheanyichukwu Onwubiko, Iboro Nta
Publikováno v:
The Lancet Global Health, Vol 7, Iss, Pp S20-(2019)
Background Isoniazid preventive therapy (IPT) significantly reduces the incidence of active tuberculosis in people living with HIV. However, despite high tuberculosis morbidity and mortality in people living with HIV, uptake of IPT remains grossly su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39b9b3f6d0221195387bef2bd4931d28
https://doi.org/10.1016/s2214-109x(19)30105-6
https://doi.org/10.1016/s2214-109x(19)30105-6